Tryptophan availability and the susceptibility to stress in multiple sclerosis: A hypothesis

International Journal of Neuroscience

Volumn 86, Issue 1-2, 1996, Pages 47-53

  Sandyk, Reuven ^a,b,c  

^a NeuroCommunication Res Laboratories   (United States)

^b TOURO COLLEGE   (United States)

^c NONE   (United States)

Author keywords

adrenal gland; cortisol; Multiple sclerosis; serotonin; stress; tryptophan

Indexed keywords

EID: 0030184163     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459608986697     Document Type: Article

References (89)

1. Abou-Saleh, M. T. and Coppen, A. J (1984). Classification of depressive illness: clinico-psychological correlates. Journal of Affective Disorder, 6, 53-66.
2. Ackenheil, M. (1980). Hormone response to stress in mental illness. In H. M Van Praag, M. H. Lader, O. J. Rafaelson and E. J. Sachar (Eds.), Handbook of biological psychiatry (part III) (pp. 195-215). New York: Marcel Dekker.
3. Ader, R., Felten, D. and Cohen, N. (1990). Interactions between the brain and the immune system. Annual Review of Pharmacology and Toxicology, 30, 561-602.
4. Ashcroft, G. W., Crawford, T. B. B., Cundall, R. L., Davidson, D. L., Dobson, J., Dow, R. C., Eccleston, D., Loose, R. W. and Pullar, I. A. (1973). 5-hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychological Medicine, 3, 326-332.
5. Beaulieu, S., Paolo, T. D. and Barden, N. (1985). Implication of the serotonergic system in the decreased ACTH response to stress after lesion of the amygdaloid central nucleus. Progress in Neuropsychopharmacology and Biological Psychiatry, 9, 665-669.
6. Bender, D. A. and Totoe, L. (1984). High doses of vitamin B6 in the rat are associated with inhibition of hepatic tryptophan metabolism and increased uptake of tryptophan into the brain. Journal of Neurochemistry, 43, 733-736.
7. Birkmeyer, W., Iselstoeger, H. and Seemann. D. (1955). Hormonstatus und Verlaufsform der Multiple Sklerose. Klinische Medizine, 10, 550-554.
8. Blalock, J. E (1989). A molecular basis for bidirectional communication between the immune system and neuroendocrine systems. Physiological Reviews, 69, 1-32.
9. Blalock, J. E. (1990). Molecular mechanisms of bidirectional communication between the immune and neuroendocrine systems. International Journal of Neuroscience, 51, 363-364.
10. Bliss, E. L., Ailion, J. and Zwanziger, J (1968). Metabolism of norepmephrine, serotonin and dopamine in rat brain with stress. Journal of Pharmacology and Experimental Therapeutics, 164, 122-134.
11. Brickner, R. M. and Simon, D. J. (1950). Emotional stress in relation to attacks of multiple sclerosis. Association for Research in Nervous Disorders Proceedings, 28, 143-146.
12. Chelmicka-Schorr, E. and Arnason, B. G. (1994). Nervous system-immune system interactions and their role in multiple sclerosis. Annals of Neurology, 36, (suppl), S29-S32.
13. Chouinard, G., Young, S. N., Annable, L. and Sourkes, T. L. (1977). Tryptophan-nicotinamide combination in depression. Lancet, 1, 249.
14. Claustrat, B., Chazot, G., Brun, J., Jordan, D. and Sassolas, G. (1984). A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biological Psychiatry, 19, 1215-1228.
15. Claveria, L. E., Curzon, G., Harrison, M. J G and Kantamaneni, B. D. (1974). Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 37, 715-718.
16. Coppen, A. J Eccleston, E. G. and Peet, M. (1973). Total and free tryptophan concentration in the plasma of depressive subjects. Lancet, 2, 60-63.
17. Coppen, A. J. and Doogan, D. P. (1988). Serotonin and its place in the pathogenesis of depression. Journal of Clinical Psychiatry, 49, (suppl. 8), 4-11.
18. Curzon, G. and Green, Ar. (1968). Effect of hydrocortisone on rat brain 5-hydroxytryptamine. Life Sciences, 7, 657.
19. Curzon, G., Joseph, M. H. and Knott, P. J. (1972). Effects of immobilization and food deprivation on rat brain tryptophan metabolism. Journal of Neurochemistry, 19, 1967-1974.
20. Davidson, D., Pullar, I. A., Mawdsley, C., Kinloch, N. and Yates, C. M. (1977). Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 40, 741-745.
21. DeKloat, E. R., Sybesma, H. and Reul, H. H. (1986). Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system Neuroendocrinology, 42, 513-521.
22. Demeyer, M. K., Shea, P. A., Hendrie, H. C. and Yoshimura, N. N. (1981). Plasma tryptophan and five other amino acids in depressed and normal subjects Archives of General Psychiatry, 38, 642-646.
23. Eccleston, D., Aschcroft, G. W., Crawford, T. B. B., Stanton, J. B., Wood, D. and Mcturk, P. H. (1970). Effect of tryptophan administration on 5-HIAA in cerebrospinal fluid in man. Journal of Neurology Neurosurgery and Psychiatry, 33, 269-272.
24. Fernstrom, J. D. and Wurtman, R. J. (1971). Brain serotonin content: physiological dependence on plasma tryptophan levels Science, 173, 149-152.
25. Fernstrom, J. D. and Wurtman, R J. (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science, 178, 414-416.
26. Fernstrom, J. D. and Faller, D. V. (1978). Neutral amino acids in the brain: changes in response to food ingestion. Journal of Neurochemistry, 30, 1531-1538.
27. Francis, G. S., Antel, J. P. and Duquette, P. (1990). Inflammatory demyelinating diseases of the CNS. In W. G. Bradley, B. Daroff, G. M. Fenichel and C. D. Marsden (Eds.), Neurology in clinical practice (p. 1154). Boston: Butterworth
28. Franklin, G., Nelson, L. and Haeton, R. (1988). Stress and its relationship to acute exacerbation in MS. Journal of Neurological Rehabilitation, 2, 7-11.
29. Freire-Garabal, M., Nunez-Iglesias, M. J., Balboa, J. L., Fernandez-Rial, J. C. and Rey-Mendez, M. (1995). Effects of buspirone on the immune response to stress in mice. Pharmacology Biochemistry and Behavior, 51, 821-825.
30. Frohman, L. A. (1980). Neurotransmitters as regulators of endocrine function. In D. T. Krieger and J. C. Hughes (Eds.), Neuroendocrinology (pp. 44-57). Sunderland, Massachusetts: Sinauer Associates, Inc.
31. Fuller, R. W. (1981) Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology, 32, 118-124.
32. Fuller, R. W., Snoddy, H. D. and Clemens, J. A. (1978). The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats. Endocrine Research Communications, 5, 161-171.
33. Gard, P. R., Handley, S. L. and Parsons, A D. (1986). A multivariate investigation of postpartum mood disturbances. British Journal of Psychiatry. 148, 567-575.
34. Grant, I., Brown, G and Harris, T (1989) Severely threatening events and marked life difficulties preceding onset or exacerbation of MS. Journal of Neurology Neurosurgery and Psychiatry, 52, 8-13.
35. Growdon, J. H., Cohen, E. L. and Wurtman, R. J. (1977). Treatment of brain disease with dietary precursors of neurotransmitters. Annals of Internal Medicine, 86, 337-339.
36. Hamon, M., Bourgoin, S., Artaud, F and EL Mestikawy, S. (1981). The respective roles of tryptophan uptake and tryptophan hydroxylase in the regulation of serotonin synthesis in the central nervous system. Journal of Physiology (Paris), 77, 269-279.
37. Handley, S. L., Dunn, T. L. and Waldron, G. (1980). Tryptophan, cortisol, and puerperal mood. British Journal of Psychiatry, 136, 498-508.
38. Hedaya, R. J. (1984) Pharmacokinetic factors in the clinical use of tryptophan. Journal of Clinical Psychopharmacology, 4, 347-348.
39. Hillier, J., Hillier, J. G. and Redfern, P. H. (1975). Liver tryptophan pyrrolase activity and metabolism of brain 5HT in rat. Nature, 253, 566-569.
40. Hollister, L. E., Davis, K. L. and Morrison Davis, B. (1980). Hormones in the treatment of psychiatric disorders. In D. T. Kneger and J. C. Hughes (Eds.), Neuroendocrinology (pp. 167-175). Sunderland, Massachusetts: Sinauer Associates, Inc.
41. Hyyppa, M. T., Jolma, T., Riekkinen, P. and Rinne, U. K (1975). Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission, 37, 297-304.
42. Imura, H., Nakai, Y. and Yoshimi, T (1973). Effect of 5-hydroxytryptophan on growth hormone and ACTH release in man. Journal of Clinical Endocrinology and Metabolism, 36, 204-211.
43. Johansson, B. and Ross, B. E. (1977) 5-hydroxymdoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology, 11, 37-45.
44. Jones, M T., Hillhouse, E. W. and Burden, J. (1976). Effect of various putative neurotransmitters on the secretion of corticotrophin releasing hormone from the rat hypothalamus in vitro. A model of the neurotransmitters involved. Journal of Endocrinology, 69, 1-20
45. Joseph, M. H. and Kennett, G. A. (1983). Corticosteroid response to stress depends upon increased tryptophan availability Psychopharmacology, 79, 79-81
46. Kennett, G. A. and Joseph, M H. (1981a). Stress induced increases in 5HT release, measured in vivo, depend upon increased tryptophan availability Neuroscienmce Letters (suppl), 7, S56.
47. Kennett, G. A. and Joseph, M. H. (1981b). The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology, 20, 39-43.
48. Kisser, W. and Harrer, G. (1974) Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift, 86, 80-82
49. Kopin, I. J. (1980). Catecholamines, adrenal hormones, and stress. In D. T Krieger and J. C. Hughes (Eds.), Neuroendocrinology (pp. 159-166). Sunderland, Massachusetts: Sinauer Associates, Inc.
50. Lewis, D. A. and Sherman, B. M. (1984). Serotonergic stimulation of adrenocorticotrophin secretion in man. Journal of Clinical Endocrinology and Metabolism, 58, 458-467.
51. Luga, N. and Hategan, D. (1986). Determination of serotonin content and ceruloplasmin activity of blood and CSF amino acid level in multiple sclerosis. Review Roumanian Medicine - Neurology and Psychiatry, 24, 153-159
52. Lynch, H. J. and Deng, M. H. (1986). Pineal responses to stress. Journal of Neural Transmission, (suppl) 21, 461-473.
53. Madaras, B. K., Cohen, E. L., Messing, R., Munro, H. N. and Wurtman, R. J. (1973). Dietary carbohydrate increases brain tryptophan and decreases free piasma tryptophan. Nature, 244, 34-35.
54. Meltzer, M. Y. and Lowry, M. T. (1987) The serotonin hypothesis of depression. In M. Y. Meltzer (Ed.), Psychopharmacology: the third generation in progress (pp. 513-526). New York: Raven Press.
55. Moller, S. E. (1980). Evaluation of the relative potency of individual competing amino acids to tryptophan transport in endogenously depressed patients. Psychiatry Research, 3, 141-150.
56. Monaco, F., Fumero, S., Mondino, A. and Mutam, R. (1979) Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry, 42, 640-641.
57. Mueller, G. P., Twohy, C. P., Chen, H. T., Advis, J. P , Meites, J. (1976). Effects of L-tryptophan and restraint stress on hypothaiamic and brain serotonergic turnover and pituitary TSH and prolactin release in rats. Life Sciences, 18, 715-724.
58. Natelson, B. H., Janocko, L. and Jacoby, J. H. (1981). An interaction between dietary tryptophan and stress in exacerbating gastric disease. Physiology and Behavior, 26, 197-200.
59. Neckers, L. and Sze, P. Y. (1975). Regulaton of 5-hydroxytryptamine metabolism in mouse brain by adrenal corticosteroids. Brain Research, 93, 123-132.
60. Pardridge, W. M. (1977). Kinetics of competitive inhibition of neutral amino acid transport across the blood brain barrier. Journal of Neurochemistry, 28, 10-18.
61. Paykel, E. S. (1978). Contribution of life events to causation of psychiatric illness. Psychological Medicine, 8, 245-253.
62. Perez-Cruet, J., Tagliamonte, A., Tagliamonte, P. and Gessa, G. L. (1972). Changes in brain serotonin metabolism associated with fasting and satiation in rats. Life sciences, 11, 31-39.
63. Plonk, J. W., Bivens, C. H. and Feldman, J. M. (1974). Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine. Journal of Clinical Endocrinology and Metabolism, 38, 836-845.
64. Poser, C M. (1992). Multiple sclerosis. Observations and reflections - a personal memoir. Journal of the Neurological Sciences, 107, 127-140.
65. Reichlin, S. (1993). Neuroendocrine-immune interactions. New England Journal of Medicine, 329, 1246-1253.
66. Richardson Morton, K. D., Van de Kar, L. D. and Lorens, S. A (1986). Stress-induced renin and corticosterone release, effect of dorsal raphe lesions and 5-HT2 antagonist. Federation Proceedings, 45, 674.
67. Rose, D. P. (1967). The influence of sex, age and breast cancer on tryptophan metabolism. Clinica Chimica Acta, 18, 221-215.
68. Roszman, T. L., Jackson, J. C., Cross, R. J., Titus, M. J., Markesbery, W. R. and Brooks, W. H. (1985). Neuroanatomic and neurotransmitter influences on immune function. Journal of Immunology, 135, 769S-772S.
69. Rudick, R. A., Goodkin, D. E. and Ransohoff, R. M. (1992). Pharmacotherapy of multiple sclerosis: current status. Cleveland Clinic Journal of Medicine, 59, 267-277.
70. Sachar, E. J. (1980). Hormonal changes in stress and mental illness. In D. T. Krieger and J. C. Hughes (Eds.), Neuroendocrinology (pp. 177-183). Sunderland, Massachusetts: Sinauer Associates, Inc.
71. Sandyk, R. (in press). Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields International Journal of Neuroscience
72. Sandyk, R., Consroe, P. and Iacono, R. P. (1986) L-tryptophan in drug-induced movement disorder with insomnia. New England Journal of Medicine, 314, 1257.
73. Schapira, K., Poskanzer, D. C., Newell, D. J. and Miller, H. (1966) Marriage, pregnancy and multiple sclerosis. Brain, 89, 419-428.
74. Shaw, D. M., Tidmarsh, S. F. and Karajgi, B. M. (1980). Tryptophan, affective disorder and stress. Journal of Affective Disease, 2, 321-325.
75. Sonninen, V., Riekkinen, P. and Rinne, U. K. (1973). Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology, 23, 760-763.
76. Sourkes, T. L. (1983). Pathways of stress in the CNS. Progress in Neuropsychopharmacology and Biological Psychiatry, 7, 389-411.
77. Squires, R. F. (1974). Hyperthermia and L-tryptophan-induced increases in serotonin turnover in rat brain. Advances in Biochemical Psychopharmacology, 10, 207-211.
78. Stein, G., Milton, F , Bebbington, P., Wood, K. and Coppen, A. (1976). Relationship between mood disturbances and free and total plasma tryptophan in postpartum women. British Medical Journal, 2, 457
79. Tabaddor, K., Wolfson, L. I. and Sharpless, N. S. (1978). Ventricular fluid homovanillic acid and 5-hydroxyin-doleacetic acid concentrations in patients with movement disorders. Neurology, 28, 1249-1253.
80. Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S. and Gessa, G. L. (1971). Effect of psychotrophic drugs on tryptophan concentration in rat brain. Journal of Pharmacology and Experimental Therapeutics, 177, 475-480.
81. Teasdale, G. M., Smith, P. A., Wilkinson, R., Latner, A. L. and Miller, H. (1967). Endocrine activity in multiple sclerosis. Lancet, 1, 64-68.
82. Tyrrell, J. B. and Forsham, P. H. (19). Glucocorticoids and adrenal androgens. In F. S. Greenspan and P. H. Forsham (Eds.), Basic and clinical endocrinology (pp. 272-283). Los Altos, California: Lange Medical.
83. Vermes, I., Smelik, P. G. and Mulder, A. H. (1976). Effects of hypophysectomy, adrenalectomy and corticosterone treatment on uptake and release of putative central neurotransmitters by rat hypothalamic tissue in vitro. Life Sciences, 19, 1719-1728.
84. Warren, S., Greenhill, S. and Warren, K. (1982). Emotional stress and the development of MS: case-control evidence of a relationship. Journal of Chronic Disease, 35, 821-831.
85. Wurtman, R. J. (1980a). The pineal as a neuroendocrine transducer. In D. T. Krieger and J. C. Hughes (Eds.), Neuroendocrinology (pp. 102-108). Sunderland, Massachusetts: Sinauer Associates, Inc.
86. Wurtman, R. J. (1980b). Nutritional control of brain tryptophan and serotonin. In O. Hayashi, Y. Ishimura and R. Kido (Eds.), Biochemcal and medical aspects of tryptophan metabolism (pp. 31-46). Amsterdam: Elsevier/North Holland.
87. Wurtman, R J. (1982). Nutrients that modify brain function. Scientific American, 246, 42-51.
88. Yehuda, R. and Meyer, J. S. (1984). A role for serotonin in the hypothalamic-adrenal response to insulin stress. Neuroendocrinology, 38, 25-32.
89. Young, S. N. (1986). The clinical psychopharmacology of tryptophan. In R. J. Wurtman and J. J. Wurtman (Eds.), Nutrition and the brain vol 7 (pp. 49-88). New York: Raven Press.